SHWZ — Medicine Man Technologies Balance Sheet
0.000.00%
- $0.62m
- $137.73m
- $172.45m
- 30
- 99
- 19
- 47
Annual balance sheet for Medicine Man Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11.9 | 1.23 | 106 | 39.4 | 19.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.17 | 1.8 | 3.87 | 4.48 | 4.26 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 15.6 | 6 | 124 | 71.7 | 53.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.299 | 5.16 | 18.8 | 45.3 | 65.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 32.2 | 70.7 | 285 | 323 | 358 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.58 | 12.4 | 45.3 | 47.4 | 55.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.65 | 28.9 | 151 | 191 | 239 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 26.6 | 41.8 | 134 | 132 | 119 |
Total Liabilities & Shareholders' Equity | 32.2 | 70.7 | 285 | 323 | 358 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |